Please login to the form below

Not currently logged in
Email:
Password:

New Accounts: April

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period March 2006 to April 2006 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period March 2006 to April 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

ABPI

The Involved Patient Initiative

N/A

Shire Health London

Altana

Pantoprazole

Gastrointestinal

Shire Health London

Astellas

Pan-European corporate profiling

Corporate

The Choice Group

AstraZeneca

Crestor

Cardiovascular

Zaicom MMC

Boehringer Ingelheim/Lilly UK

Cymbalta

Neurology

Virgo Health PR

Cephalon

Actiq

Pain

TVF Communications

GE Healthcare Europe

DaTSCAN

Diagnostic/neurology

Succinct Communications

GlaxoSmithKline

Kivexa

HIV

90TEN Healthcare

GlaxoSmithKline

New product

Oncology

Succinct Communications

NICE

At Ri-SK? awareness campaign

Solar keratosis

hsdcommunications

Novartis

Diovan/Codiovan

Hypertension

TVF Communications

Novartis

OTC

Skincare products

Toniq

Novartis

Prexige

Osteoarthritic pain

LeapFrog Medical Communications

Pfizer

5th Ann Meet of Institute of Arthritis & Pain

Arthritis and pain

Zaicom MMC

Pfizer

Vfend

Haematology

Zaicom MMC

Recordati

Zanidip

Cardiology

LeapFrog Medical Communications

Sankyo

Olmetec

Hypertension

Athena Medical PR

Schering-Plough

Nasonex

Respiratory disease

LeapFrog Medical Communications

 

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics